AGI.do

Products

What will AGI do for Ascomycin?

This classification denotes an immunosuppressant and a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AUF4U5NSJK, chemically known as (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-ethyl-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0?,?]octacos-18-ene-2,3,10,16-tetrone but more generally known as ascomycin, which bears US NIH Compound Identifier 5282071. Most nations, for tariff and trade purposes, schedule ASCOMYCIN under HS 29349990 and SITC 51579. SMILES: CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C.

How AGI delivers it

Four ways AGI delivers for Ascomycin

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Ascomycin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Ascomycin, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Ascomycin connects

measured by

  • Assay Puritymodel
  • Compound Puritymodel
  • Fermentation Yieldmodel
  • Optical Rotationmodel

Go deeper

Explore Ascomycin

Read the deeper take on agi.asView as markdown